Product Comparison
No Image |
|
|
No Image |
|
|
|---|---|---|---|---|---|
| McKesson # | 1150397 | 209165 | 467160 | 1235732 | 1204499 |
| Description | Dobutamine HCl / Dextrose 5% 1 mg / mL Solution 250 mL | Dopamine HCl / Dextrose 5%, Preservative Free 1600 mcg / mL Solution 250 mL | Dopamine HCl / Dextrose 5% 1600 mcg / mL Solution 250 mL | Dobutamine HCl, Preservative Free 12.5 mg / mL Injection 20 mL | Dobutamine HCl, Preservative Free 12.5 mg / mL Injection 20 mL |
| Manufacturer # | 2B0793 | 00409780922 | 2B0842 | 70436020382 | 1016940 |
| Brand | |||||
| Manufacturer | Baxter | Pfizer | Baxter | Slate Run Pharmaceuticals | Healthfirst |
| Invoice | DOBUTAMINE HCL, SOL 5% 1000MG/250ML (18/CS) | DOPAMINE HCL, IV SOL 400MG/250ML 5% DEX (12/CS) | DOPAMINE HCL, IV SOL 400MG/250ML 5% DEX (18/CS) | DOBUTAMINE HCL, VL 250MG/ML 20ML (10/CT) | DOBUTAMINE, VL 12.5MG/ML 20ML (10/BX) |
| Log In to Order | Log In to Order | Log In to Order | Log In to Order | Log In to Order | |
Comparison |
|||||
| Alternate Manufacturer Number | 2818276 | ||||
| Alternate Packaging | CS/12 | CS/18 | EA/1 | ||
| Container Type | Flexible Bag | Flexible Bag | Flexible Bag | Single-Dose Vial | Single-Dose Vial |
| Country of Origin | Puerto Rico | Unknown | United States | Unknown | Italy |
| Dosage Form | Solution | Solution | Solution | Injection | Injection |
| Generic Drug Code | 00978 | 15353 | 15353 | 14575 | 14575 |
| Generic Drug Name | Dobutamine HCl / Dextrose 5% | Dopamine HCl / Dextrose 5%, Preservative Free | Dopamine HCl / Dextrose 5% | Dobutamine HCl, Preservative Free | Dobutamine HCl, Preservative Free |
| Latex Free Indicator | Not Made with Natural Rubber Latex | ||||
| NDC Number | 00338107702 | 00409780922 | 00338100702 | 70436020382 | 51662133703 |
| Strength | 1 mg / mL | 1600 mcg / mL | 1600 mcg / mL | 12.5 mg / mL | 12.5 mg / mL |
| UNSPSC Code | 51392408 | 51393801 | 51393801 | 51392408 | 51392402 |
| Volume | 250 mL | 250 mL | 250 mL | 20 mL | 20 mL |
| Application | Beta-Adrenergic Agonist | Beta-Adrenergic Agonist | Beta-Adrenergic Agonist | Beta-Adrenergic Agonist | Beta-Adrenergic Agonist |
| Product Dating | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Type | Intravenous | Intravenous | Intravenous | Intravenous | Intravenous |
| Features and Benefits |
|
|
|
|
|